What I Wish Everyone Knew About 144222-22-0

The article 《Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication》 also mentions many details about this compound(144222-22-0)Name: 1-Boc-4-(Aminomethyl)piperidine, you can pay attention to it or contacet with the author([email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]) to get more information.

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: 1-Boc-4-(Aminomethyl)piperidine( cas:144222-22-0 ) is researched.Name: 1-Boc-4-(Aminomethyl)piperidine.Li, Qilan; Lomonosova, Elena; Donlin, Maureen J.; Cao, Feng; O’Dea, Austin; Milleson, Brienna; Berkowitz, Alex J.; Baucom, John-Charles; Stasiak, John P.; Schiavone, Daniel V.; Abdelmessih, Rudolf G.; Lyubimova, Anastasiya; Fraboni, Americo J.; Bejcek, Lauren P.; Villa, Juan A.; Gallicchio, Emilio; Murelli, Ryan P.; Tavis, John E. published the article 《Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication》 about this compound( cas:144222-22-0 ) in Antiviral Research. Keywords: hepatitis B virus replication amide alpha hydroxytropolone; Hepatitis B Virus; Molecular modeling; Ribonuclease H; α-Hydroxytropolones. Let’s learn more about this compound (cas:144222-22-0).

The Hepatitis B Virus (HBV) RNase H (RNaseH) is a promising but unexploited drug target. Here, we synthesized and analyzed a library of 57 amide-containing α-hydroxytropolones (αHTs) as potential leads for HBV drug development. Fifty percent effective concentrations ranged from 0.31 to 54μM, with selectivity indexes in cell culture of up to 80. Activity against the HBV RNaseH was confirmed in semi-quant. enzymic assays with recombinant HBV RNaseH. The compounds were overall poorly active against human RNase H1, with 50% inhibitory concentrations of 5.1 to >1,000μM. The aHTs had modest activity against growth of the fungal pathogen Cryptococcus neoformans, but had very limited activity against growth of the Gram – bacterium Escherichia coli and the Gram + bacterium Staphylococcus aureus, indicating substantial selectivity for HBV. A mol. model of the HBV RNaseH templated against the Ty3 RNaseH was generated. Docking the compounds to the RNaseH revealed the anticipated binding pose with the divalent cation coordinating motif on the compounds chelating the two Mn++ ions modeled into the active site. These studies reveal that that amide aHTs can be strong, specific HBV inhibitors that merit further assessment toward becoming anti-HBV drugs.

The article 《Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication》 also mentions many details about this compound(144222-22-0)Name: 1-Boc-4-(Aminomethyl)piperidine, you can pay attention to it or contacet with the author([email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]; [email protected]) to get more information.

Reference:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem